ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 140 filers reported holding ANIKA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,494 | -93.0% | 7,917 | -90.2% | 0.00% | -100.0% |
| Q2 2023 | $2,102,873 | +104.6% | 80,942 | +126.1% | 0.00% | 0.0% |
| Q1 2023 | $1,028,004 | +5.7% | 35,794 | +8.9% | 0.00% | 0.0% |
| Q4 2022 | $972,863 | +24.7% | 32,867 | +0.4% | 0.00% | – |
| Q3 2022 | $780,000 | +4.0% | 32,741 | -2.5% | 0.00% | – |
| Q2 2022 | $750,000 | -13.6% | 33,594 | -2.8% | 0.00% | – |
| Q1 2022 | $868,000 | -31.8% | 34,554 | -2.6% | 0.00% | -100.0% |
| Q4 2021 | $1,272,000 | -16.2% | 35,494 | -0.4% | 0.00% | 0.0% |
| Q3 2021 | $1,517,000 | -1.0% | 35,627 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $1,532,000 | +127.0% | 35,390 | +113.7% | 0.00% | – |
| Q1 2021 | $675,000 | +50.7% | 16,559 | +67.3% | 0.00% | – |
| Q4 2020 | $448,000 | -3.0% | 9,897 | -24.2% | 0.00% | – |
| Q3 2020 | $462,000 | -87.6% | 13,062 | -86.8% | 0.00% | -100.0% |
| Q2 2020 | $3,723,000 | +23.7% | 98,694 | -5.2% | 0.00% | 0.0% |
| Q1 2020 | $3,010,000 | -52.4% | 104,125 | -14.7% | 0.00% | -25.0% |
| Q4 2019 | $6,324,000 | +1033.3% | 122,000 | +1096.5% | 0.00% | – |
| Q3 2019 | $558,000 | -65.5% | 10,196 | -74.4% | 0.00% | -100.0% |
| Q2 2019 | $1,617,000 | -53.7% | 39,879 | -65.5% | 0.00% | -50.0% |
| Q1 2019 | $3,492,000 | +1.8% | 115,566 | +13.2% | 0.00% | 0.0% |
| Q4 2018 | $3,429,000 | -84.2% | 102,049 | -80.2% | 0.00% | -66.7% |
| Q3 2018 | $21,742,000 | +4.6% | 515,489 | -20.7% | 0.01% | 0.0% |
| Q2 2018 | $20,791,000 | +208.9% | 649,791 | +380.0% | 0.01% | +100.0% |
| Q1 2018 | $6,730,000 | +37.9% | 135,384 | +49.5% | 0.00% | 0.0% |
| Q4 2017 | $4,880,000 | +22.6% | 90,584 | +31.9% | 0.00% | 0.0% |
| Q3 2017 | $3,982,000 | +27.3% | 68,678 | +8.2% | 0.00% | +50.0% |
| Q2 2017 | $3,129,000 | -5.7% | 63,476 | -17.0% | 0.00% | 0.0% |
| Q1 2017 | $3,318,000 | +16.8% | 76,435 | +31.7% | 0.00% | 0.0% |
| Q4 2016 | $2,840,000 | -32.9% | 58,037 | -34.4% | 0.00% | -33.3% |
| Q3 2016 | $4,233,000 | -33.0% | 88,503 | -24.9% | 0.00% | -25.0% |
| Q2 2016 | $6,318,000 | +71.5% | 117,795 | +42.9% | 0.00% | +33.3% |
| Q1 2016 | $3,685,000 | +130.6% | 82,458 | +96.7% | 0.00% | +200.0% |
| Q4 2015 | $1,598,000 | +6.8% | 41,921 | -10.9% | 0.00% | 0.0% |
| Q3 2015 | $1,496,000 | -19.3% | 47,066 | -16.1% | 0.00% | 0.0% |
| Q2 2015 | $1,853,000 | +12.8% | 56,125 | +40.5% | 0.00% | 0.0% |
| Q1 2015 | $1,643,000 | -28.8% | 39,941 | -29.5% | 0.00% | 0.0% |
| Q4 2014 | $2,308,000 | +96.6% | 56,667 | +76.9% | 0.00% | 0.0% |
| Q3 2014 | $1,174,000 | -64.2% | 32,041 | -54.8% | 0.00% | -50.0% |
| Q2 2014 | $3,280,000 | -8.6% | 70,816 | -18.9% | 0.00% | -33.3% |
| Q1 2014 | $3,588,000 | +492.1% | 87,326 | +449.1% | 0.00% | – |
| Q4 2013 | $606,000 | +77.7% | 15,904 | +11.2% | 0.00% | – |
| Q3 2013 | $341,000 | – | 14,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |